Condition
KRAS G12C Lung Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 KRAS G12C Lung Cancer clinical trials that are recruiting, at sites in 28 countries (most in China (2), Argentina (1), Australia (1)). By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 28Countries
All recruiting trials (2)
-
Garsorasib and Ivonescimab with Chemo Before Surgery for KRAS G12C NSCLC
This trial tests whether giving garsorasib followed by ivonescimab with chemotherapy before surgery helps people with resectable KRAS G12C-mutant NSCLC.
-
Divarasib plus pembrolizumab versus pembrolizumab with pemetrexed and platinum chemotherapy for first-line KRAS G12C advanced non-squamous non-small cell lung cancer
This trial tests whether adding divarasib to pembrolizumab works better than standard pembrolizumab with pemetrexed plus carboplatin or cisplatin for adults with untreated, KRAS G12C-mutant advanced non-squamous non-small cell lung cancer.
Related topics
Quick answers
How many KRAS G12C Lung Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 28 countries. The most sites are in China (2 trials), Argentina (1 trial), Australia (1 trial), Belgium (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.